Recursion Pharmaceuticals Announces Formation of Its Scientific and Technical Advisory Board
Summary
Recursion announced the formation of its Scientific and Technical Advisory Board today, along with the appointment of Dr. Anne Carpenter and Dr. Kirk Thomas as its first two members.Salt Lake City, UT, April 12, 2014 --( These experts, along with several others to be announced at a later date, will advise Recursion Pharmaceuticals on a wide range of topics including scientific strategy, new technology, clinical impacts, and drug development.Data from these assays is probed using advanced statistical and machine learning approaches, and the effects of thousands of drug candidates can be investigated efficiently to identify those holding the most promise for the treatment of any one rare genetic disease.Our first two appointments exemplify this stance, and help bring perspective as we seek to use a unique combination of experimental biology and bioinformatics to develop our first orphan drugs.”The first two members of the Recursion Pharmaceuticals Scientific and Technical Advisory Board are:Anne Carpenter, Ph.D.Dr.Data from these assays is probed using advanced statistical and machine learning approaches, and the effects of thousands of drug candidates can be investigated efficiently to identify those holding the most promise for the treatment of any one rare genetic disease.See www.recursionpharma.com for more information.